What is BPC-157 and what does it do
While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds
Using multiple peptides may increase uncertainty around safety, side effects, and treatment response
For researchers investigating skin biology at the cellular and molecular level, this compound is one of the most well-characterised tools available
Right after the injection, you may experience mild discomfort at the injection site, such as slight redness, swelling, or tenderness
We are very pleased to demonstrate 20.7% weight loss and to see that 33% of patients achieved more than 25% weight loss with semaglutide 7.2 mg, with a safety and tolerability profile comparable to semaglutide 2.4 mg, said Martin Holst Lange, executive vice president for Development at Novo Nordisk